Autoimmune polyglandular syndrome type 1 market
The autoimmune polyglandular syndrome type 1 market was valued at USD 228 million in 2021 and is expected to reach USD 347.26 million by 2029, registering a CAGR of 5.40% during the forecast period of 2022 to 2029.   Autoimmune Polyglandular Syndrome Type 1 Market Dynamics Drivers Rise in the number of cases of autoimmune polyglandular syndrome type 1 The surging number of cases of...
0 Comments 0 Shares
Sponsored